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OBJECTIVE—Regenerating organs in diverse biological sys-
tems have provided clues to processes that can be harnessed to
repair damaged tissue. Adult mammalian -cells have a limited
capacity to regenerate, resulting in diabetes and lifelong reliance
on insulin. Zebraﬁsh have been used as a model for the regener-
ation of many organs. We demonstrate the regeneration of adult
zebraﬁsh pancreatic -cells. This nonmammalian model can be
used to deﬁne pathways for islet-cell regeneration in humans.
RESEARCH DESIGN AND METHODS—Adult transgenic ze-
braﬁsh were injected with a single high dose of streptozotocin or
metronidazole and anesthetized at 3, 7, or 14 days or pancreate-
ctomized. Blood glucose measurements were determined and gut
sections were analyzed using speciﬁc endocrine, exocrine, and
duct cell markers as well as markers for dividing cells.
RESULTS—Zebraﬁsh recovered rapidly without the need for
insulin injections, and normoglycemia was attained within 2
weeks. Although few proliferating cells were present in vehicles,
ablation caused islet destruction and a striking increase of
proliferating cells, some of which were Pdx1 positive. Dividing
cells were primarily associated with affected islets and ducts but,
with the exception of surgical partial pancreatectomy, were not
extensively -cells.
CONCLUSIONS—The ability of the zebraﬁsh to regenerate a
functional pancreas using chemical, genetic, and surgical ap-
proaches enabled us to identify patterns of cell proliferation in
islets and ducts. Further study of the origin and contribution of
proliferating cells in reestablishing islet function could provide
strategies for treating human diseases. Diabetes 58:1844–1851,
2009
T
he adult endocrine pancreas functions as a reg-
ulator of blood glucose levels by virtue of insu-
lin-secreting -cells contained within the
pancreatic islets of Langerhans. Destruction or
malfunction of -cells results in hyperglycemia and diabe-
tes, often requiring lifelong insulin therapy. Damage to
differentiated tissues, such as the human liver, can elicit
regeneration through the activation and division of reserve
quiescent adult cells. However, the pancreas has little
capacity to be replaced when damaged and typically
responds to insults through inﬂammatory repair mecha-
nisms (1). Unlike repair, regeneration is a process of
controlled cell proliferation and patterning that restores
the entire tissue. Regeneration is associated with neogen-
esis in the adult and the replacement of diverse cell types.
Adult zebraﬁsh are capable of regrowing an entire ﬁn,
including cartilage, muscles, and nerves, by a process
known as epimorphic regeneration (2). In contrast, a
severed mammalian appendage fails to regenerate, al-
though newborn mice temporarily retain the regenerative
memory that zebraﬁsh can utilize for wound repair
throughout their life span (3). Limited regrowth of adult
mammalian islets can occur after injury; however, if
hyperglycemia persists, insulin therapy is required and
inﬂammatory responses severely limit the restitution of
lost tissue.
The main zebraﬁsh pancreas is both anatomically (4)
and developmentally (5) similar to the mammalian pan-
creas, whereas major differences are apparent in other ﬁsh
species. In adult zebraﬁsh, the main pancreas contains
several principal islets surrounded by exocrine tissue. A
tail of single islets embedded in exocrine tissue and fat
extends caudally along the intestine. In contrast, the
-cells of tilapia (another glucose-sensitive teleost ﬁsh)
reside in Brockman bodies or isolated islets located along
the mesentery that are not surrounded by exocrine tissue
(6,7). In embryonic zebraﬁsh, recent investigation has
revealed the capacity to recover ablated -cell mass with
restoration of the islet without a requirement for exocrine
cells (8,9). However, adult zebraﬁsh were not evaluated in
these studies and it is not clear that -cell recovery after
removal of the drug was a reinitiation of developmental
pathways. In adult mammals, cell division from preexist-
ing, differentiated -cells appears to be the primary means
of tissue replacement (10), although severe forms of
impairment such as partial duct ligation induce replication
of insulin-negative -cell progenitors within ducts that
later become insulin-positive -cells (11). In mammals,
wounding the pancreas by chemical (12) or physical (13)
means does not result in a signiﬁcant replacement of lost
tissue, while subsequent insulin administration increases
the number of -cells per islet, especially in young ani-
mals. Chemical-induced pancreatitis causes a hyperplasia
of tubular structures (14), and islet morphogenesis from
ducts has been observed in several developmental as well
as disease models (15), supporting the role of pancreatic
ducts in islet neogenesis. In contrast to these mammalian
models, the current study demonstrates a functional re-
generation of the adult zebraﬁsh islet after ablation using
two different models of drug-induced damage and surgical
removal. We visualized islets directly in the adult because
transgenic zebraﬁsh expressed bright ﬂuorescence only in
-cells. Islet regeneration resulted in a return to normal
size and function of the islets with no requirement for
insulin therapy. Analysis of the expression of hormone
(glucagon, insulin), Pdx1 (transcription factor), and a
marker of zebraﬁsh ductal and vascular eptithelium [cyto-
From the
1Sarah W. Stedman Nutrition and Metabolism Center, Duke Univer-
sity Medical Center, Durham, North Carolina; the
2Tufts Center for
Regenerative and Developmental Biology, Tufts University, Medford, Mas-
sachusetts; the
3Department of Pathobiology, Institute of Anatomy, Uni-
versity of Veterinary Medicine, Vienna, Austria; and the
4Department of
Surgery, Johns Hopkins University, Baltimore, Maryland.
Corresponding author: Jennifer B. Moss, jennifer.b.moss@duke.edu.
Received 9 May 2008 and accepted 14 May 2009.
Published ahead of print at http://diabetes.diabetesjournals.org on 9 June
2009. DOI: 10.2337/db08-0628.
© 2009 by the American Diabetes Association. Readers may use this article as
long as the work is properly cited, the use is educational and not for proﬁt,
and the work is not altered. See http://creativecommons.org/licenses/by
-nc-nd/3.0/ for details.
The costs of publication of this article were defrayed in part by the payment of page
charges. This article must therefore be hereby marked “advertisement” in accordance
with 18 U.S.C. Section 1734 solely to indicate this fact.
ORIGINAL ARTICLE
1844 DIABETES, VOL. 58, AUGUST 2009keratin 18 (CK18)] revealed a contribution of Pdx1

dividing cells to the regenerate. The unusual ability of the
adult zebraﬁsh to regenerate appendages and internal
organs provides new opportunities for probing changes in
-cell mass in the adult, with the ultimate goal of adapting
knowledge gained from this unique system to the devel-
opment of strategies for inducing human -cell
regeneration.
RESEARCH DESIGN AND METHODS
Zebrafish strains and maintenance. Adult InsGFP (16) and wild-type
(Tu ¨bingen AB) zebraﬁsh maintained in our recirculating system (Aquatics
Habitat) were 1 year old before manipulation. InsGFP zebraﬁsh (Tg(1.0ins:
eGFP)sc1) are now available from ZIRC (http://zﬁn.org). Tg(T2Kins:nfsB-
mCherry)
jh4 ﬁsh (abbreviated to InsNTR) express a nitroreductase (NTR)
mCherry fusion protein in the -cells (8) and were used at 8 months old for
ablation studies. After treatment, experimental ﬁsh were kept in isolation
tanks with daily water changes. Institutional animal facility Institutional
Animal Care and Use Committee protocols were followed for all experiments.
Streptozotocin or metronidazole treatment and surgical resection. The
dose of streptozotocin (STZ) (no. S0130, Sigma) required to extinguish -cell
GFP ﬂuorescence was ﬁrst determined by culturing pancreatic explants in
supplemented RPMI media (17) at 28°C without CO2. A similar dose of alloxan
(no. A6316, Sigma) also caused -cell necrosis after 3 days in culture (data not
shown). A dose curve using 200, 400, 800, and 1,000 mg/kg STZ (n  6 for each
dose) indicated that a single-high intraperitoneal dose of 1 g/kg STZ caused
loss of green ﬂuorescent protein (GFP) ﬂuorescence. Metronidazole (MET)
(no. M3761, Sigma) was injected at 0.25 g/kg. Intraperitoneal injections of
alloxan (0.2 g/kg) caused greater lethality and less reproducibility, primarily
because of liver failure. STZ or MET dissolved in 5 mmol/l citrate, pH 5, was
injected with pulled capillary pipets inserted into the holder of a microinjector
(Eppendorf). The effectiveness of the injection was monitored by adding 0.25%
phenol red, resulting in a diffuse pink color throughout the ﬁsh within 15 min.
Zebraﬁsh were anesthetized with tricaine (18) and revived within 30 s after
gentle swirling of system water through the gills. Surgeries were aided using
a dissection microscope equipped with ﬂuorescence (Leica) to detect endog-
enous islet InsGFP expression. Anesthetized adults were placed on a sponge
exposing their right side. Number 55 forceps were used to penetrate the body
wall and remove the GFP-positive main pancreas. Experimental subjects
recovered within 1 min and were maintained individually for 3, 7, or 14 days
in 28°C system water while monitored for rapid gill movement or hemorrhage.
Blood glucose determination. Fasted adults were weighed, anesthetized,
and placed on a wet sponge, and a pulled capillary pipet was inserted into the
atrium of the beating heart. Approximately 50 nl of blood was removed and
rapidly transferred to a Freestyle glucose monitor strip. We did not use blood
from the tail vein because this technique caused more lasting damage than
heart puncture. Blood glucose measurements from InsNTR ﬁsh were taken at
sacriﬁce and anesthetized in 4°C ﬁsh water for 2 min because of required
changes in our animal protocol. Recordings were evaluated statistically using
Student’s t test. At least six vehicle-injected and 10 drug-injected animals were
used at each regeneration time point. At the termination of each experiment,
zebraﬁsh were weighed and ﬁnal blood glucose determinations were made.
Zebraﬁsh were killed according to established protocols (18).
Histology immunohistochemistry and microscopy. Excised gut sections
were placed in buffered 2% paraformaldehyde overnight at 4°C. Parafﬁn
embedding was achieved using minimal times in solutions (30 min), after
which 5 micron serial sections were cut. We were able to select GFP- or
mCherry-positive sections while still in parafﬁn before, as well as after,
antibody treatment (19). Fluorescence microscopy images were recorded
with a Hamamatsu CCD camera using a Leica MZFlIII dissecting microscope
or a Zeiss Axioskop. Confocal images were made on a Zeiss LSM 410
microscope. Primary antibodies were used according to the manufacturer’s
recommendations: proliferating cell nuclear antigen (PCNA), NeoMarkers;
insulin, Linco Research; glucagon, Dako; (cyto) keratin 18, Progen (Germany).
The Pdx1 guinea pig anti-zebraﬁsh peptide polyclonal antibody was a gener-
ous gift from Chris Wright (Vanderbilt). The secondary antibodies for 488, 546,
and 647 nm were acquired from Molecular Probes (Alexa Fluor). We repro-
duced PCNA results with BrdU (no. B9285, Sigma) injections (data not
shown). Antigen retrieval was preformed using Dako products. Images were
acquired and processed using Openlab software (Improvision) and Adobe
Photoshop CS2.
RESULTS
Zebrafish islet tissue is destroyed by exposure to
STZ. We initially tested whether zebraﬁsh islets were
susceptible to the toxic effects of STZ, a nitrosourea
causing DNA damage after entering -cells through the
Glut2 receptor. Adult zebraﬁsh containing a stable trans-
gene expressing GFP from the zebraﬁsh insulin promoter
only in -cells (InsGFP [16]) were anesthetized, and the
main GFP-positive pancreatic tissue was excised and
incubated for 3 days in media used for culturing rat
primary islets (17). At 0 or 20 mmol/l STZ, no gross
changes in GFP ﬂuorescence or morphology were detect-
able. However, at 100 and 200 mmol/l STZ, signiﬁcant loss
of GFP-positive cells was observed in culture (Fig. 1A).
These data provided the basis for examining the physio-
logical effects of -cell destruction in living InsGFP
zebraﬁsh.
The zebraﬁsh main pancreas is located on the right side
of the adult ﬁsh, attached to the lateral aspect of the
duodenum by the pancreatic duct (20). Typically, one large
islet and 3–6 smaller islets occupy the main pancreas of
the adult zebraﬁsh. The tail of the pancreas is embedded
with single -cells or clusters of small GFP-positive islets
and extends caudally along the right side of the intestine
(Fig. 1B). We evaluated a range of STZ doses from 200
mg/kg to 1,000 mg/kg and determined that a single high
dose of 1 g/kg reduced GFP ﬂuorescence in vivo (Fig. 1B).
This dose suggested a relative resistance of zebraﬁsh islets
to -cell toxins (7) compared to the mouse. Lethality at
doses greater than 1 g/kg was correlated with damage to
other organs and/or death. Injections were performed on
day 0 before the morning shrimp meal. Unlike controls,
normal feeding behavior was delayed in STZ-injected
zebraﬁsh until 12–24 h postinjection. After 3 days, signiﬁ-
cant loss of ﬂuorescence in the islets could be observed in
injected animals when compared with controls (Fig. 1B).
To determine if the loss of GFP expression was associated
with -cell necrosis, propidium iodide was applied in situ
immediately after death to the pancreas of STZ-treated
zebraﬁsh or controls. STZ-injected animals showed a dra-
matic loss of GFP-positive cells and an increase of ne-
crotic, propidium iodide–positive cells within the islet
when compared with vehicle (Fig. 1C and D).
Functional assessment of -cell loss in STZ- and
MET-injected zebrafish. To evaluate if the loss of ﬂuo-
rescent -cells produced a physiological change, blood
glucose levels in zebraﬁsh at 3, 7 or 14 days after drug
injection were measured (Fig. 2). The collected blood was
rapidly discharged onto a strip containing adsorbed glu-
cose oxidase, routinely used by human diabetic patients to
monitor blood glucose (Freestyle). To acquire a baseline,
fasted blood glucose readings were compared between
male and female as well as wild-type versus transgenic
animals. An average fasted adult zebraﬁsh blood glucose
reading was 57.4 mg/dl  4.1 mg/dl (n  96). STZ-injected
blood glucose levels increased at least two-fold after 3
days and returned to normal after 2 weeks without inter-
vention (Fig. 2, black bars). Reports of STZ-induced rodent
hyperglycemia have indicated a much larger increase of
blood glucose readings after treatment. This may be due
either to greater hydration secondary to hyperglycemia in
zebraﬁsh or to liver toxicity from drug administration
(data not shown). In consideration of potential detrimen-
tal effects of STZ on tissues other than the pancreatic
-cells, we also evaluated a -cell intrinsic ablation system
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toxic compound that damages DNA in zebraﬁsh embryos,
causing -cell apoptosis. Blood glucose readings for In-
sNTR-mCherry transgenics, recorded at time of death, also
increased 3 days after injection and then fell to normal
levels after 2 weeks. The observation that the 3 day MET
blood glucose readings were higher than the STZ-treated
reading at this time point suggests that -cell ablation may
have been more complete in the InsNTR transgenics.
Time course of STZ-mediated cell death and
regeneration. A histological study of adult zebraﬁsh
islets was used to evaluate the surprising return to normo-
glycemia without the need for insulin administration.
Excised gut fragments including the proximal intestine
and attached ﬂuorescent main pancreas were ﬁxed and
embedded in parafﬁn. Figure 3 compares stained and
immunoﬂuorescence-hybridized sections of vehicles with
STZ-injected zebraﬁsh at 3, 7, and 14 days. Hematoxylin
and eosin staining showed the main islet was frequently
absent and smaller islets were invested with lymphocytic
inﬁltrates and/or necrotic cells after 3 days (Fig. 3A). The
islet perimeter was often discontinuous or aberrant (Fig.
3B and C). Weak insulin (Fig. 3B) or GFP (Fig. 3C) staining
after 3 days conﬁrmed a loss of -cells while dividing
PCNA-positive cells appeared at the islet perimeter,
whereas vehicle-injected zebraﬁsh contained dividing
PCNA-positive cells primarily in the intestine (Fig. 3B).
Insulin-positive cells were not dividing. Glucagon staining
indicated a disruption of islet geometry after 3 days (Fig.
3C). After 7 days, small insulin-positive islets were rarely
found. We occasionally observed GFP-positive -cells
within ductal epithelium (Fig. 3B, inset), though dividing
cells were not insulin positive. Glucagon marked the
perimeter of GFP-positive islets (Fig. 3C, inset) and out-
lined adjacent structures that appeared to emanate from
ducts, visible after 7 days. After 2 weeks, numerous islets
were present, and unlike controls, glucagon-positive cells
were prominent in ductal epithelium (Fig. 3A and C).
Larger islets contained scattered PCNA-positive cells com-
parable to vehicle-injected zebraﬁsh after 14 days (Fig.
3B).
Regeneration after MET injection of -cell–speciﬁc
NTR conditional transgenics. Because InsNTR ze-
braﬁsh treated with MET also had elevated blood glucose
levels that returned to normal after 2 weeks (Fig. 2), we
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0 20 100 200
A
B
Vehicle
+ STZ
Rostral
C
Vehicle + PI
D
STZ + PI
FIG. 1. -cell destruction by STZ. A: GFP ﬂuorescence of zebraﬁsh
pancreatic explants after 3 days in culture (100). B: Intact zebraﬁsh:
lateral views of right side without skin (50). Top panel: GFP ﬂuores-
cence in the main pancreas (rostral) and auxiliary islets (green) of
vehicle-injected zebraﬁsh. Bottom panel: STZ-injected zebraﬁsh killed
after 3 days. C: Vehicle-injected, killed InsGFP zebraﬁsh. Main pan-
creas was imaged after in situ treatment with propidium iodide (pro-
pidium iodide: red ﬂuorescence). D: STZ-injected zebraﬁsh pancreas 
propidium iodide after 3 days. (A high-quality digital representation of
this ﬁgure is available in the online issue.)
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FIG. 2. Blood glucose levels return to normal after 2 weeks. Fasted
blood glucose readings were recorded from cardiac blood in STZ-
treated (black bars) versus vehicle-treated (white bars) zebraﬁsh at 3,
7, and 14 days from 10 (5 male/5 female) STZ- and 6 (3 male/3 female)
vehicle-injected InsGFP 1-year-old siblings. A two-fold reduction in
blood glucose was observed 1 week after destruction of the -cells.
Gray bars: blood glucose readings from fasted InsNTR 1 year olds 3, 7,
or 14 days after MET treatment. IP, intraperitoneal.
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tion in dividing cells and ducts (Fig. 4). A CK18 antibody
(20) was used to label ducts. We employed a zebraﬁsh-
speciﬁc Pdx1 antibody (gift of Chris Wright) to identify
prospective -cells. Pdx1 is a homeodomain protein re-
quired for the organogenesis of the pancreas as well as
maintenance of the -cell phenotype (21). Pdx1 expres-
sion in wild-type adult zebraﬁsh islets has previously been
demonstrated using antisense probes (22). Compared with
vehicle-injected InsNTR adults (Fig. 4A), PCNA
 cells
were found in and around ablated islets after 3 days (Fig.
4B), similar to the STZ-ablation phenotype. Insulin
 cells
were absent. By 14 days, -cells had reappeared and
divided at levels similar to the vehicle-injected controls.
However, more PCNA
 cells were present outside the islet
after 2 weeks (Fig. 4C). Although islet architecture had
been disrupted, -cells were not actively dividing after 3
or 14 days (Fig. 4B and C, Glu/PCNA). As for vehicle-
injected zebraﬁsh (Fig. 4A), the pancreatic ductal epi-
thelial cells were labeled with the Pdx1 antibody at 3
days (Fig. 4B). As seen after STZ treatment, more ducts
were present 14 days after injection of MET and were
labeled by the Pdx1 antibody (Fig. 4C). Small numbers
of dividing, Pdx1
 cells appeared in control zebraﬁsh
(Fig. 4A). After 3 days, large numbers of Pdx1
 cells
were dividing (Fig. 4B) in islets and ducts. Cells labeled
with both Pdx1 and PCNA were numerous in both islets
and within ductal epithelia after treatment (Fig. 4C),
although signiﬁcant numbers of PCNA
/Pdx1
 cells
were also observed.
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FIG. 3. Regeneration of zebraﬁsh islets after STZ treatment. A: Hematoxylin and eosin (H&E) staining of paraffin sections at 3, 7, and 14 days.
Vehicle and 14 day STZ: 200 magniﬁcation; 3 day and 7 day: 400 magniﬁcation. Arrows: islets. Arrowheads: blood vessels. B: STZ Ins/PCNA:
insulin antibodies (visualized with red ﬂuorescent secondary antibodies) mark -cells. PCNA
 dividing cells are green. Arrows identify islets.
Arrowheads: ducts; vehicle: numerous dividing PCNA
 cells are located at the base of intestinal villi. A few non–insulin expressing dividing cells
are scattered throughout the islet and surrounding exocrine pancreas (400 magniﬁcation); 3 day STZ: a mantle of PCNA-positive cells
surrounds affected islets (400); 7 day STZ: dividing cells are located in and around ducts (400 magniﬁcation); inset (200 magniﬁcation):
CK18 (red) labeling of ducts. Insulin
 cells are green; 14 day STZ: 200 magniﬁcation. Large islets with scattered dividing cells have appearance
similar to vehicle-injected zebraﬁsh. Dividing cells surround insulin-negative areas, similar to the PCNA expression observed after 3 days. C: STZ
glucagon/GFP; vehicle (400 magniﬁcation): -cells (green) and -cells (red). Arrow: islet; 3 day STZ: glucagon
 cells within islet remnant
(400); 7 day STZ: glucagon labels GFP-negative islet attached to duct (200). Inset (400): glucagon (red) outlines islets  -cells (green);
14 day STZ: ductal hyperplasia (200) with glucagon staining (red). Inset (600): the ductal epithelium is continuous with the islet (confocal
image). (A high-quality digital representation of this ﬁgure is available in the online issue.)
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braﬁsh were pancreatectomized (Ptx) or manipulated with
forceps without removing GFP-positive tissue (sham-
operated control). We removed as much of the GFP-positive
tissue as possible without severely damaging the liver, gall
bladder, or spleen. After 7 days, the wound had healed and
GFP-positive cells were photographed in situ (Fig. 5A vs. B).
Blood glucose readings in Ptx ﬁsh killed after 14 days were
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FIG. 4. Regeneration of islets after metronidazole treatment. 200 magniﬁcation. i  islets, int  intestine. Each column contains serial sections
except one: 14 day InsNTR, Glu/PCNA. A: Vehicle InsNTR. DIC: differential interference contrast image indicating location of pancreatic islets
and ducts. Ins/PCNA: sparse, dividing PCNA
 cells (green) in endocrine islets (red, insulin). Arrow: dividing -cell. Glu/PCNA: glucagon
 cells
(red) primarily at the perimeter of the islet. Pdx1/CK18: Pdx1
 cells located in CK18
 (green) ductal epithelium (arrowhead and inset).
Pdx1/PCNA: nondividing Pdx1
 cells throughout the islet and ducts (arrowhead and inset). Arrow: dividing cell. B: Three day InsNTR. Ins/PCNA:
-cells are absent. Dividing cells (green) occupy the islet. Extra-islet cells are also dividing. Glu/PCNA: glucagon
 cells (red) are not dividing.
Centrally located -cells. Pdx1/CK18: Pdx1
 (red) cells depicted (inset) in islets and numerous ducts (arrowheads). Pdx1/PCNA: many Pdx1

cells (red) are also dividing (arrows and insert). Many dividing Pdx1
 cells (inset) are located in ducts (arrowhead). C: Fourteen day InsNTR.
Ins/PCNA: regenerated -cells in islet (red) occasionally divide (arrow). Glu/PCNA: dividing cells (green) located in and around regenerated islet
(-cells are red). Pdx1/CK18: ducts and vascular epithelium (CK18: green) and Pdx1
 cells (red). Pdx1/PCNA: Pdx1 (red) labels islets, ducts
(arrowhead), and occasionally intestine (green). Arrows: dividing Pdx1
 cells. (A high-quality digital representation of this ﬁgure is available in
the online issue.)
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normal blood sugars (52.4 mg/dl, n  4). Fibrotic tissue was
observed along with a proliferation of small islets. A histo-
logical assessment indicated that, like the STZ-treated ﬁsh,
ductal elements were associated with regenerating tissue.
Dividing cells were not prominent in the pancreas of sham-
operated animals, whereas numerous PCNA-positive cells
were found in pancreatic ducts (Fig. 5C). Surprisingly, unlike
the chemical-ablation models, PCNA co-stained many insu-
lin-positive cells (Fig. 5D). The partial physical ablation
caused by pancreatectomy resulted in an increased division
of existing -cells that was not observed after chemical
ablation. In contrast, ductal hyperplasia and a prominent
association of regenerating islets with ducts were required
for both wound repair and the regeneration we observed
after STZ or MET treatment.
DISCUSSION
Animal models provide insights as well as controversies
regarding -cell regeneration. In human type 1 diabetes or
rodent models of extensive -cell loss, insulin replacement
is required for survival in the face of severe hyperglycemia
and other metabolic derangements. Although there is grow-
ing evidence that some degree of -cell regeneration does
occur in these settings, it is inadequate to eliminate the
need for insulin therapy. In contrast, we observed 8–12
month old zebraﬁsh recovering spontaneously from hyper-
glycemia after chemical treatment or pancreatectomy
without the need for insulin therapy (the average life span
for a zebraﬁsh in captivity is 42 months [23]). This physi-
ological improvement correlated with a return of insulin-
positive -cells observed in histological sections. We
ascertained whether the population of dividing cells could
be characterized using an early pancreatic/-cell precursor
marker such as Pdx1. Our results deﬁne some of the
dividing cells in both islets and adjacent pancreatic ducts
as Pdx1 positive. Although the cells within the islet could
have originated locally or migrated from a distance, the
presence of dividing Pdx1 cells in the islets as well as
within adjacent pancreatic ducts suggests that these cells
may be a possible source for -cell progenitors. Subse-
quent studies using lineage-tracing strategies will be ex-
ploited to more rigorously deﬁne the origins of -cell
precursors in the adult zebraﬁsh and delineate the role of
pancreatic ducts in the regeneration process.
During epimorphic regeneration, common in urodele
amphibians, proliferating undifferentiated mesenchymal
cells accumulate at wound sites, promoting regeneration
in a process that is distinct from the ﬁbrosis and inﬂam-
mation associated with mammalian wound repair (24).
Although sources of mesenchymal cells are not well
understood, proliferation of resident cardiomyocytes oc-
curs after resection of the zebraﬁsh heart to rebuild
muscle without scarring (25). These proliferating cells
apparently use a genetic program distinct from embryonic
heart development because unique genes were upregu-
lated during regeneration (26). Ablative treatment of
insulin nitroreductase zebraﬁsh embryos causes existing
insulin-positive cells as well as non–insulin expressing
cells at the periphery of the islet to divide (8,9). However,
during embryogenesis, the recovery of the -cell popula-
tion may be a continuation of developmentally pro-
grammed organogenesis and different from regeneration
in adults (27). In adult zebraﬁsh, it is not clear if islet
regeneration recapitulates development.
B
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FIG. 5. Regeneration after pancreatectomy. A and B: Right side of
intact, living zebraﬁsh before (sham, A) and 14 days after (Ptx, B)
surgical removal of the GFP
 pancreas (red outline). The tip of the
forceps used to remove the pancreas is visible (100 magniﬁcation). C:
Parafﬁn section of sham-operated pancreas with few PCNA
 dividing
cells (PCNA, red) except in the intestine (Int). -Cells are green
(arrow; 200 magniﬁcation). D: Many red PCNA
 dividing cells in
ducts (arrowhead) and in nuclei of regenerating -cells (yellow; 200
magniﬁcation). (A high-quality digital representation of this ﬁgure is
available on the online issue.)
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ating cells during regeneration depends on the nature and
degree of the insult. A number of indications from human
and rodent -cell proliferation studies both support and
reject this conclusion. For example, STZ treatment re-
sulted in permanent -cell loss and hyperglycemia in
6-month-old mice unless hyperglycemia was ameliorated
by insulin administration (12). In addition, human autopsy
specimens from normal or type 1 diabetic patients pro-
vided evidence for limited -cell replication though no
differences were found in pancreatic ducts (28). However,
90% pancreatectomy in rats elicited -cell proliferation
along with apparent differentiation of cells within pancre-
atic ducts to -cells (29). Recent work suggests that new
-cells may arise from cells expressing carbonic anhy-
drase II, presumably pancreatic ductal epithelium (30). In
1-week-old mice, a 70% pancreatectomy caused -cell
expansion only by replication of preexisting -cells (31),
which could be an example of compensatory growth when
an adequate number of -cells remain. In contrast, a
robust regeneration of -cells from undifferentiated pro-
genitors was seen after pancreatic duct ligation in
1-month-old mice (11). Although we identiﬁed ductal hy-
perplasia and elevated numbers of dividing cells in the
islets and pancreatic ducts of surgical as well as chemical
ablation models, insulin-positive -cells divided only after
pancreatectomy. Surgical removal, which affects many
more cell types than -cells, may have triggered a distinct
set of signals that in aggregate leads to -cell proliferation.
Alternatively, surviving -cells may be induced to undergo
compensatory growth in response to unmet systemic
demands. Therefore, observations regarding -cell regen-
eration are highly dependent on the experimental model
employed and islet regeneration processes may be opera-
tive in young mammals that are either absent or compro-
mised in older adults. These new adult animal models of
diabetes will be useful in deﬁning the roles of dividing cells
as well as pancreatic ducts during -cell regeneration.
We suggest that the capacity of the adult zebraﬁsh to
regenerate islet tissue to an extent mammals cannot
makes the zebraﬁsh a powerful system with which to
address fundamental questions of -cell regeneration. The
ability to speciﬁcally test regenerating -cells in an in vivo
compartment where all the environmental inﬂuences of
cytokines, wound repair, inﬂammation, etc., are in place
provides a platform for discovering the signals required for
the reestablishment of -cell function and glycemic ho-
meostasis. Unique factors may be identiﬁed from the
zebraﬁsh model that could be applied to diabetes treat-
ment either by inducing endogenous -cell regeneration or
by expanding the -cell mass of transplanted islets.
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